Table 2.

List of diagnostic criteria for HLH that were used in the Histiocyte Society HLH-2004 study

(A) Genetic defect consistent with HLH or (B) 5 out of 8 clinical and laboratory criteria fulfilled 
 Fever 
 Splenomegaly 
 Cytopenia in ≥2 cell lineages 
  Hemoglobin <9 g/dL, in neonates <10 g/dL 
  Platelet count <100 × 103/mL 
  Neutrophil count <1 × 103/mL 
 Hypertriglyceridemia (>265 mg/dL) or hypofibrinogenemia (<150 mg/dL) 
 Hyperferritinemia (>500 ng/mL) 
 Soluble CD25 >2400 U/mL (or elevated compared with laboratory-defined normal ranges) 
 Hemophagocytosis in bone marrow, spleen, lymph nodes, or liver 
 Low or absent NK-cell cytotoxicity 
(A) Genetic defect consistent with HLH or (B) 5 out of 8 clinical and laboratory criteria fulfilled 
 Fever 
 Splenomegaly 
 Cytopenia in ≥2 cell lineages 
  Hemoglobin <9 g/dL, in neonates <10 g/dL 
  Platelet count <100 × 103/mL 
  Neutrophil count <1 × 103/mL 
 Hypertriglyceridemia (>265 mg/dL) or hypofibrinogenemia (<150 mg/dL) 
 Hyperferritinemia (>500 ng/mL) 
 Soluble CD25 >2400 U/mL (or elevated compared with laboratory-defined normal ranges) 
 Hemophagocytosis in bone marrow, spleen, lymph nodes, or liver 
 Low or absent NK-cell cytotoxicity 

According to the revised diagnostic criteria guideline of the HLH-2004 protocol, HLH is assumed if either a genetic diagnosis consistent with HLH is present (A) or if 5 out of 8 criteria are fulfilled (B). The finding of a genetic defect does not mean that a patient has acute hyperinflammatory HLH, only that they have a predisposition to the syndrome of HLH.10 

or Create an Account

Close Modal
Close Modal